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• The fate of parent and polar PAHs in a biomonitoring species was assessed 51 
• Quantitative monitoring of PACs was carried out on Sydney rock oysters for 86 days 52 
• Parent PAHs, NPAHs and 9-FLO significantly depurated from oyster tissues 53 
• There was no clear depuration of nearly all oxyPAHs and HPAHs  54 
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Graphical Abstract 55 




Increasing our understanding of the bioavailable fractions of polycyclic aromatic compounds 58 
(PACs) in an aquatic environment is important for the assessment of the environmental and 59 
human health risks posed by PACs. More importantly, the behaviour of polar polycyclic 60 
aromatic hydrocarbons (polar PAHs), which are metabolites of legacy PAHs, are yet to be 61 
understood. We, therefore, carried out a study involving Sydney rock oysters (Saccostrea 62 
glomerata) sourced from two locations, that had been exposed to PAH contamination, within 63 
an Australian southeast estuary. Biomonitoring of these oysters following relocation from the 64 
estuary to a relatively isolated waterway was done at 24 and 72 h after deployment, and 65 
subsequently at 7, 14, 28, 52 and 86 days. Control samples from Camden Haven River were 66 
sampled for PAC analyses just before deployment, after 28 days and at the end of the study 67 
(day 86). Lipid-normalised concentrations in oyster tissues across the 86-day sampling 68 
duration, elimination rate constants (k2), biological half-lives (t1/2), and time required to reach 69 
95% of steady-state (t95), were reported for parent PAHs and the less-monitored polar PAHs 70 
including nitrated/oxygenated/heterocyclic PAHs (NPAHs, oxyPAHs and HPAHs) for the 71 
three differently sourced oyster types. Most of the depurating PAHs and NPAHs, as well as 9-72 
FLO (oxyPAH), had k2 values significantly different from zero (p < 0.05). All other oxyPAHs 73 
and HPAHs showed no clear depuration, with their concentrations remaining similar. The non-74 
depuration of polar PAHs from oyster tissues could imply greater human health risk compared 75 
to their parent analogues. 76 
 77 
Keywords: Polar PAHs, Saccostrea glomerata, Biomonitoring, Elimination rate constant, 78 
Biological half-lives, Aquatic environment  79 
  80 
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1. Introduction 81 
The fate of polycyclic aromatic compounds (PACs) in the natural environment is of critical 82 
importance from a human and environmental health risk perspectives. Exposure to PACs can 83 
result in numerous toxicological effects, including carcinogenesis, mutagenesis and 84 
teratogenesis 1-4. Polar polycyclic aromatic hydrocarbons (polar PAHs) have varying 85 
physicochemical properties both as a group and in comparison to their parent analogues 5, 6. 86 
These differing physicochemical properties result in varied behaviour and the eventual fate of 87 
PACs in the environment. To date, most emphasis has been on the environmental fate of the 88 
non-polar parent PAHs compared to polar PAHs such as oxygenated PAHs (oxyPAHs), 89 
nitrated PAHs (NPAHs) and heterocyclic PAHs (HPAHs) 7. In recent years, and with the 90 
increasing knowledge of the potentially greater toxicity and bioavailability of polar PAHs, 91 
investigation of their fate and behaviour is increasing, albeit mostly focusing on soil and 92 
particulate matter in the air, rather than in aquatic environments 8-14.  93 
Polycyclic aromatic compounds are amongst the most abundant contaminants in the aquatic 94 
environment 15, 16, which can be taken up by aquatic species. Exposure to PACs can arise from 95 
dissolved and particulate organic carbon fractions from the incomplete combustion of organic 96 
matter 17. Alternatively, sediments are global sinks for PACs, which can be remobilised into 97 
water and ultimately bio-accumulate in living organisms15, 18-20. The bioavailability of PACs 98 
and other hydrophobic contaminants in aquatic organisms is of great essence since the 99 
bioavailable concentrations are directly related to the toxic effects in organisms including 100 
humans 15, 21. The natural regenerative ability of water bodies, particularly rivers, makes water 101 
PAC concentrations, at any point in time, a poor predictor of bioavailability 17. Accordingly, 102 
the evaluation of contaminant bioavailability in aquatic environments has commonly been 103 
made using benthic invertebrates such as mussels, clams and oysters 17, 22-26. Monitoring of 104 
PAC concentrations in such organisms has provided a more definitive means of evaluating the 105 
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bioavailable fractions in an aquatic environment. Depending on their lipophilic characteristics, 106 
PACs could be bio-accumulated in the lipid-rich tissues of oysters or remain in the water phase 107 
15, 17, 23. The high rate of bioaccumulation compared to elimination through metabolism, is 108 
mostly the reason for PACs’ bioaccumulation in oyster and other sentinel organisms used as 109 
aquatic biomonitors 17. 110 
Apart from providing information about the health of an environment, bivalves are a popular 111 
food source in many areas around the world, and global seafood consumption rates are rising 112 
27. Early commercialisation of the Sydney Rock Oyster (Saccostrea glomerata) in New South 113 
Wales (NSW) and Southern Queensland began in the late 1700s but the expansion and  114 
development of the oyster industry that formed the basis of the current aquaculture industry 115 
dates back to the early 1900s 28, 29. Sydney rock oysters have historically been exposed directly 116 
to petrogenic PACs through the use of coal tar and its derivatives in preserving the timber 117 
infrastructure from marine borers 28. Even though they have generally been phased out from 118 
use, PACs are still present in the sediment beneath many farming areas.  119 
Recycled plastic products are now being used in place of tarred hardwood infrastructure in 120 
shellfish aquaculture of most NSW estuaries, due to their ease of use and durability 28. 121 
However, this replacement could also have potential negative impacts on the surrounding 122 
environment and oyster consumers as plastics could be a direct source of PACs 30, 31. Other 123 
important sources of PACs such as motor vehicle exhaust, forest and rangeland burning, oil 124 
spills, industrial processes and run-off could have contributed to the estuary’s sediment PAC 125 
load 32, 33. Oysters that have bio-accumulated environmental contaminants in their tissues may 126 
cause chronic health anomalies in humans, especially if consumed over a long period of time 127 
32. It, therefore, means that despite the ecological importance of bivalves, they could act as a 128 
vector for PACs to humans. 129 
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Toxicokinetic parameters such as uptake rates (k1), elimination rates (k2) and biological half-130 
lives (t1/2), have been used to describe parent PAH bioaccumulation/elimination patterns in 131 
oysters 17, 23, 34. Such studies provide information about the fate of PAHs in an organism 132 
including its bio-accumulative potential, contaminant transformation possibilities, elimination 133 
duration and toxicity. In this way, food regulatory authorities have been able to predict the 134 
safety of consuming naturally sourced delicacies. 135 
Unlike parent PAHs, the fate of the bioavailable fraction of polar PAHs in oysters and other 136 
biomonitoring organisms that also serve as food has not been well researched. Further, most of 137 
the studies for parent PAHs in the literature are laboratory-based, with very few field studies 138 
on PAC bioaccumulation/elimination dynamics. In furtherance of our earlier study on the 139 
bioaccumulation of parent and polar PAHs in the tissues of S. glomerata 35, the present study 140 
set out to carry out on-field quantitative biomonitoring of the bioavailable fractions of parent 141 
PAHs, oxyPAHs, NPAHs and HPAHs in the tissues of Sydney rock oysters sourced from a 142 
south-east Australian estuary. To the best of our knowledge, this is the first study to 143 
simultaneously investigate the elimination patterns of parent and polar PAHs in oysters from 144 




2. Materials and Methods 147 
2.1 Oyster sampling 148 
Oyster samples were collected from two locations (A and B) close to the mouth of a south-east 149 
Australian estuary (Fig. 1).  The choice of the estuary was based on recent testings by the NSW 150 
Food Authority (NSWFA) and our previously published article on the estuary sediment, oyster 151 
and water concentrations 35, which showed that it was experiencing higher than expected levels 152 
of PAC contamination. The oysters were collected around potential sources of PACs such as 153 
boat ramp, historical residual tar deposits and roadside drains (Fig. 1). A location non-154 
disclosure agreement was entered into with NSW fisheries authorities during the sampling 155 
period, preventing us from showing the global positions on the map. 156 
For the depuration study, approximately 200 sampled adult oysters of approximately equal 157 
sizes were relocated to a relatively isolated waterway, surrounded by a National Park, with low 158 
PAC background levels not exceeding those reported in the source estuary (NSWFA 159 
unpublished data). The relocated oysters were here held in three replicate batches in plastic 160 
cages on existing oyster culture infrastructure. Oysters translocated to the isolated waterway 161 
were tested 24 and 72 h after deployment and subsequently at Day 7, 14, 28, 52 and 86. On 162 
each sampling occasion, 15 randomly selected oysters were tested from each of the 3 replicate 163 
batches. Control oysters sourced from Camden Haven River, which has a history of low PAH 164 
concentrations (NSWFA unpublished data) were also monitored for concentration changes at 165 
the time of translocation (time 0), and again at 28 and 86 days later.   166 
 2.2. Extraction procedures and PAC analysis 167 
The extraction of parent and polar PAHs from freeze-dried oysters was performed using the 168 
QuEChERS approach. A 2 g dried homogenised oyster tissue sample was transferred to a 169 
QuEChERS extraction tube, and 20 µl of 100 µg/ml acenaphthene-d10 and fluoranthene-d10 170 
recovery standards and QuEChERS extraction salt (containing NaCl (1 g), MgSO4 (4 g), 171 
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Na3C6H5O7 (1 g) and C6H6Na2O7·1.5H2O) were added. A mixture of (4:1 v/v) of 172 
hexane/acetone (20 ml) was added as extraction solvent followed by shaking with the aid of a 173 
vortex for 1 min and centrifugation (2000 xg at 4°C for 10 min). The supernatant was 174 
subsequently transferred to a QuEChERS cleanup tube and vortexed (1 min), centrifuged at 175 
2000 xg and 4 °C (10 min) and concentrated using a nitrogen concentrator at 35 °C and 12.5 176 
psi to about 500 µl. 177 
The concentrated extracts were applied to 2 g preconditioned 10% activated silica solid-phase 178 
extraction cartridges connected to a manifold and operated under vacuum at 5 mmHg. The 179 
fractionating procedure into parent and polar PAH fractions was done using 15 ml Hexane: 180 
DCM (5:1) for parent PAHs and 8 ml DCM followed by 5 ml acetone, for polar PAHs. The 181 
volume of eluent was concentrated to near dryness, solvent exchanged to hexane by adding 1 182 
ml hexane and transferred to 1.5 ml GC vial for GC-MS analysis. Four deuterated internal 183 
standard mix (naphthalene-d8, phenanthrene-d10, pyrene-d10 and perylene-d12) was added 184 
prior to GC-MS analysis. The concentrations of the individual PACs were normalized against 185 
the lipid fraction of the organism. Oyster percent lipid content (12.3) was determined by the 186 
modification of a previously used method 36. Extracted samples were centrifuged at 500 rpm 187 
and concentrated to dryness using a nitrogen concentrator. The lipid content was the relative 188 
weight of the dried residual. Further details on the analytical methods and quality control 189 
procedures can be found in the Supplementary Information and previously published papers 33, 190 
37. 191 
2.3. Computation of kinetic parameters 192 
Contaminant elimination from oyster is generally considered to follow first-order kinetics on a 193 
natural log scale17, 23: 194 
d𝐶𝐶o
dt






 is the change in PAC concentration in oyster tissues over the change in time. 197 
Integrating, the equation becomes: 198 
lnCo,t = - k2*t + lnCo,0 199 
Where lnCo,t is the lipid normalized PAC concentration in oyster tissues at time t and initial 200 
time (t = 0); k2 is elimination rate constant which is absolute value of the slope of a plot of lnCo 201 
and t. 202 
The k2 values are useful in calculating biological half-lives (t1/2) and time required to reach 95% 203 
of steady state (t95). These are computed as: 204 
t1/2 = ln2/ k2 205 
t95 = - ln 0.05/ k2 206 
Elimination rate constants were evaluated through the determination of the slope of the ln-207 
transformed PACs’ lipid-normalized concentrations and time. The kinetic parameters were 208 
computed for PACs that showed visibly reduced concentrations in computed linear regression 209 
equations. 210 
  211 
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3. Results and Discussion 212 
3.1.      Concentration changes in polar and parent PAHs over the depuration period 213 
As a build-up on our earlier published article where the concentrations of PACs in water, 214 
sediments and oyster tissue samples were reported for the contaminated site (locations A and 215 
B) 35, the depuration of parent and polar PAHs from the tissues of adult Sydney rock oysters 216 
were investigated in the current study. 217 
The HPAH mean concentrations in oysters sourced from locations A and B of the estuary were 218 
relatively similar over the 86 days of study (Fig. 2A). For location A-sourced oysters, mean 219 
concentrations of 2-MBF, for example, at the beginning and end of the investigation, were 220 
0.047 and 0.040 µg/g (Table S1, supplementary information). Mean concentrations of 2-MBF 221 
for locations A and B-sourced and control oysters were not significantly different from one 222 
another (p > 0.05) over the 86-day depuration study (Fig. 2A). The same trend of similar ‘day 223 
1’ and ‘day 86’, not significantly different locations A and B- sourced and control oyster 224 
concentrations were observed for DBF, XAN, THIA, QUI, IND, 8-MQL and ACRI for the 225 
depuration period (Fig. 2A). Mean concentrations of HPAHs were generally less than 0.5 µg/g 226 
except for a few concentration spikes observed in few instances (Table S1). 227 
Following the same trend as HPAH, the oxyPAH locations A and B-sourced and control oyster 228 
tissue mean concentrations were not significantly different (p > 0.05), and concentrations were 229 
relatively similar across the 86-day depuration period (Fig. 2B). Lipid-normalized 230 
concentrations of oxyPAHs were about 100 order of magnitudes lower than HPAHs 231 
concentrations (Table S2; Fig 2B.) with concentrations mostly below 0.1µg/g (Table S2). Out 232 
of the seven monitored oxyPAHs in this study, only 9-FLO concentrations showed slight 233 
decrease in oyster tissues. 9-FLO concentration in locations A and B-sourced oysters reduced 234 
to 0.0022 and 0.0024 µg/g from 0.0064 and 0.0058 respectively (Table S2). 235 
12 
 
The location A-sourced mean lipid-normalized concentrations of 1N-NAP in oyster were 236 
significantly different from location B-sourced and control oyster concentrations (p < 0.05), 237 
which in turn were not significantly different from each another (Fig. 2C). 1N-NAP 238 
concentrations increased in location A-sourced and control oysters from 24.6 and 1.28 to 599 239 
and 292 µg/g, respectively, within the 86 days of investigation (Table S3). Concentrations of 240 
1N-NAP in location B-sourced oysters, within the same duration, were relatively dissimilar 241 
(Fig. 2C). The increasing concentrations of 1N-NAP in oysters for locations A and B, may be 242 
due to recurring fluxes of naphthalene from ready sources and the subsequent secondary 243 
formation of 1N-NAP (Table S3), which is a metabolite of naphthalene. Declining 244 
concentrations were however noticed in location A and B-sourced, and control oyster 245 
concentrations for 2N-FLU and 9N-ANT (Table S3) with no significant difference (p > 0.05) 246 
in mean concentrations (Fig. 2C). Mean concentrations of 2N-FLU in location A-sourced (0.91 247 
µg/g), location B-sourced (0.98 µg/g) and control oyster (0.73 µg/g) were down to 0.20, 0.18 248 
and 0.17 µg/g by the 86th day, respectively (Table S3). For 9N-ANT, initial concentrations in 249 
locations A and B-sourced and control oysters were 0.75, 0.72 and 0.64 µg/g while the 250 
concentrations by the last day of the study, declined to 0.15, 0.14 and 0.31 respectively (Table 251 
S3). 252 
Parent PAH lipid-normalized locations A and B-sourced, and control oyster tissue mean 253 
concentrations, were not significantly different (p > 0.05) in this study (Fig 2D). PAH 254 
concentrations showed marked decline within the depuration period (Fig 2D). Location A-255 
sourced oyster FLUA concentration (24,307 µg/g) was the highest PAH concentration at the 256 
start of the depuration study, but it reduced considerably to 4.3 µg/g by the 86th day. Location 257 
A-sourced oyster PYR and PHEN concentrations also declined from 14,802 and 6,542 µg/g to 258 
2.7 and 1.9 µg/g, respectively (Table S4). The use of tar in infrastructure for shellfish 259 
aquaculture may have been a contributing factor to the elevated concentrations at the start of 260 
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the study. Concentrations of low molecular weight (LMW) and high molecular weight (HMW) 261 
PAHs in oyster were generally very low, at the start of the study, compared to the 262 
concentrations of mid-range molecular size PAHs such as FLUA and PYR. High 263 
concentrations of PAHs of mid-range molecular size and hydrophobicity in the tissues of oyster 264 
could be as a result of the loss of smaller, volatile analytes and the insufficient partitioning of 265 
strongly hydrophobic chemicals in water for uptake by the bivalve 23. 266 
Overall, the concentrations of PACs in oyster tissues across the 86-day study was relatively 267 
similar for polar PAHs while marked reduction in concentrations were recorded for parent 268 
PAHs. The sustained low concentrations might imply a possible equilibrium between oyster 269 
tissues and water polar PAH concentrations with potential environmental and human health 270 
risks, especially because of the proven greater toxicity of polar PAHs compared to their parent 271 
analogues 6, 38, 39. 272 
3.2.    Toxicokinetics of parent and polar PAHs in the Sydney rock oyster 273 
The concentrations of the monitored parent PAHs in location A-sourced, location B-sourced 274 
and control oyster samples of the estuary declined throughout the depuration period except for 275 
FLU with seemingly rising concentrations (Fig. S2). For NPAHs, concentrations of 1N-NAP 276 
in the tissues of oyster did not show a declining trend (locations B and control) (Fig. S2) like 277 
2N-FLU and 9N-ANT concentrations (Fig. S1I and S1J). 9-FLO was the only oxyPAH with a 278 
declining trend over the 86-day depuration study (Fig. S1K). Similarly, all HPAHs investigated 279 
in this study did not exhibit visible elimination by the 86th day (Fig. S2). The non-declining 280 
trend in HPAHs, oxyPAHs (all but one), 1N-NAP and FLU may be indicative of their possible 281 
non-bioaccumulation in oyster tissues.  282 
The elimination rate constants k2, for bio-accumulated PAHs, 2N-FLU, 9N-ANT (NPAHs) and 283 
9-FLO (oxyPAH), were evaluated by determining the slope of the linear regression between 284 
their ln-transformed concentrations in oyster tissues and time 23. For parent PAHs, only PHEN, 285 
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ANTH, FLUA, PYR, I[cd])P and D[a,h]A had k2, values which were significantly different 286 
from zero (p < 0.05) (Fig. S1).  287 
Elimination rate constant values, for parent PAHs, ranged from 0.02 – 0.11 day -1 in location 288 
A-sourced oysters and 0.001 – 0.09 day -1 in location B-sourced oysters (Table 2). 2N-FLU 289 
and 9N-ANT k2 values of 0.03 and 0.02 day -1, respectively, in location A-sourced oysters and 290 
0.03 day -1 in location B-sourced oysters (Table 2) were significantly different from zero (p < 291 
0.05). Similarly, for 9-FLO, the k2 value for both location A and location B-sourced oysters 292 
(0.01 day -1) was significantly different from zero (p < 0.05). There was no significant value of 293 
k2 recorded for any control oyster. Similarly, the k2 values of ACENY, ACEN, B[a]A, CHRY, 294 
B[b+k]F and B[a]P were not significantly different from zero (p > 0.05) for all oyster types 295 
(Table 2). Elimination rate constant were in the order location A-sourced > location B-sourced 296 
> control oysters implying that elimination of PACs may be concentration dependent since 297 
PAC oyster concentrations followed the same order. 298 
The t1/2 for location A-sourced, location B-sourced and control oysters were not significantly 299 
different (p > 0.05) and ranged from 6.4 (PHEN and FLUA) to 53.9 days (9-FLO) for location 300 
A-sourced, 8.1 (PHEN) to 647.8 days (B[a]P) for location B-sourced and 9.7 (PYR) to 98.5 301 
days (B[b+k]F) for control oysters (Table 2). Similarly, t95 values were not significantly 302 
different (p > 0.05) for location A and B-sourced oysters, and control. It ranged from 27.6 303 
(PHEN and FLUA) to 232.8 days (9-FLO) for location A-sourced, 35.0 (PHEN) to 2800 days 304 
(B[a]P) for location B-sourced and 41.8 (PYR) to 425.5 days (PYR) for control oysters (Table 305 
2).  306 
The kinetic parameters for locations A and B-sourced, and control oysters, in this study, did 307 
not have the same values. This difference may be due to different environmental dynamics 308 
including varying PAC concentrations in water and sediment for the estuary (locations A and 309 
B), Camden Haven River and the isolated waterway. Varying values were particularly noticed 310 
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in PAHs (e.g. B[b+k] and B[a]P) whose slope were not significantly different from zero (p > 311 
0.05) (Table 2).  312 
Studies on the elimination of PACs from aquatic organisms are very scarce in the literature. As 313 
far as we know, there are no past investigations on the elimination of polar PAHs from an 314 
aquatic organism. Few studies have however investigated the elimination dynamics of PAHs 315 
from bivalves. A comparison of the parent PAH kinetic parameters obtained in this study and 316 
two previous studies revealed that location A-sourced computations were closest to the 317 
literature values (Table 3). For example, location A-sourced oyster B[a]A k2 value in this study 318 
(0.095 day -1) compares very well with the value of 0.092 day-1 for mussels (Elliptio 319 
complanata) 17 (Table 3). Close comparison also existed in I[cd]P and D[a,h]h k2 values of 320 
0.039 and 0.046 day -1 in this study, and 0.047 and 0.069 day -1 respectively, for the study on 321 
mussels 17 (Table 3). ACENY k2 value was 0.034 in this study compared to 0.046 day -1 in a 322 
much ealier study also on E. complanata 23. Arising from the similar k2 values of this study and 323 
the two previous studies, the half-life values were also similar (Table 3). Half-life values for 324 
D[a,h]A in this study and one of the studies were both 15.1 days 17. For I[cd]P, it was 14.7 days 325 
in E. complanata 17 and 17.8 days in this study. PHEN, ANTH, FLUA, PYR and B[a]A values 326 
in this study were just a little higher than values in E. complanata 23 (Table 3). Without 327 
considering CHRY, which is the only parent PAH with a marked difference in k2 and t1/2 values, 328 
the t95 values (for parent PAHs) ranged from 27.6 (PHEN and FLUA) to 95.5 days (ACEN) in 329 
this study as well as 16.9 (PHEN) to 64.7 days (ACENY)  and 12.6 (ACEN) to 63.7 days 330 
(I[cd]P) respectively, in the two previous studies 17, 23 (Table 3). The reason for the difference 331 
with CHRY is unclear.  332 
The k2, t1/2 and t95 values for 1N-NAP, FLU, all oxyPAHs (except 9-FLO) and all HPAHs were 333 
not computed because of thier variable behaviour as seen in their rising ln concentration with 334 
time for all three differently sourced oysters (Fig. S2). The rising concentrations might have 335 
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resulted from higher bioavailability of these contaminants from water due to their less 336 
hydrophobic nature. The kinetic parameters for the polar PAHs have common attributes of 337 
lower k2 values and longer t1/2 and t95 compared to the parent PAHs. These imply their slower 338 
rate of elimination compared to parent PAHs. The PAC with the longest computed t1/2 value 339 
(53.9 days) and t95 value (232.8 days), in this study, is 9-FLO: a polar PAH (Table 3). 340 
3.3.      Relationship between elimination rate constants (k2) and log Kow for parent and  341 
polar PAHs 342 
 343 
The varying rates of elimination of bio-accumulated parent and polar PAHs from oysters may 344 
be related to their physicochemical properties and particularly log Kow. The linear regression 345 
model of k2 and log Kow for parent PAHs and polar PAHs (Fig. S3) could provide a description 346 
of the possible relationship existing between these two parameters for the particular PAC type. 347 
Simple linear regression analysis of k2 versus log Kow for (A) parent PAHs and (B) polar PAHs 348 
(Fig. S3), for locations A and B-sourced and control oysters, yielded varying results. For parent 349 
PAHs, equations k2 = -0.016 log Kow + 0.26,  -0.018 log Kow + 0.12 and -0.014 log Kow + 0.12 350 
were obtained with r2 values of 0.25, 0.34 and 0.47 for locations A and B-sourced and control 351 
oysters, respectively (Fig. S3). Though not significant (p > 0.05), the inverse relationship 352 
between k2 and Kow showed that the parent PAHs were being passively eliminated from the 353 
oyster tissues. Based on the r2 values,  the variability in k2 that could be explained by log Kow 354 
was as much as 25, 34 and 47% for location A-sourced, location B-sourced and control oysters 355 
respectively. These are high percentages considering the fact that the depuration study was 356 
conducted in the field and other competing factors could have influenced the rate of depuration. 357 
Similar r2 values of k2 and Kow for parent PAHs have been reported in the literature 17, 23, 40, 41.   358 
Non-significant (p > 0.05) positive relationships were however observed in polar PAHs when 359 
a simple linear regression analysis was performed for k2 and log Kow, for locations A and B, 360 
indicating that the polar PAHs might not have been eliminated from oyster tissues possibly 361 
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because of their bioavailability from surrounding water. Very low r2 values computed for 362 
locations A and B oysters (0.04 and 0.05), indicated that the proportion of variability in k2 that 363 
could be explained by log Kow was very low (Fig. S3). For the control oysters, a non-significant 364 
(p > 0.05) negative relationship existed between k2 and Kow (Fig. S3) implying possible passive 365 
depuration of polar PAHs from oyster tissues. This could probably be due to the prevalence of 366 
polar PAHs in control oysters particularly from parent PAH transformation, compared to 367 
oysters from the two other locations. 368 
  369 
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4.0 Conclusions 370 
The toxicokinetics of parent PAHs and the less monitored polar PAHs (NPAHs, oxyPAHs and 371 
HPAHs) in S. glomerata were investigated with a first-order, one-compartment, linear model. 372 
Oysters relocated from a southeast Australian estuary to a comparably clean isolated waterway 373 
in NSW Australia, demonstrated varied elimination rates of parent and polar PAHs. Parent 374 
PAHs (except FLU) substantially bio-accumulated in oyster tissues and demonstrated 375 
impressive elimination rates in the isolated waterway. Similarly, two of the three investigated 376 
NPAHs had significant k2 values implying strong depuration from oyster tissues. All oxyPAHs 377 
(except 9-FLO) and HPAHs exhibited low depuration with their concentrations remaining 378 
fairly constant. FLU, 1N-NAP and 9-FLO demonstrated varied behaviour compared to other 379 
members of their individual groups with rising concentrations of FLU and 1N-NAP, and 380 
reducing concentration of 9-FLO from oyster tissues. Unlike parent PAHs, polar PAH did not 381 
exhibit considerable depuration from oyster tissues as their k2 values largely exhibited direct 382 
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SI-Text 1: Chemicals and reagents 40 
The following chemicals were purchased from Sigma Aldrich, Australia: 41 
PAH mix containing: acenaphthylene (ACENY), acenaphthene (ACEN), fluorene (FLU), 42 
phenanthrene (PHEN), anthracene (ANTH), fluoranthene (FLUA), pyrene (PYR),  benz[a] 43 
anthracene (B[a]A), chrysene (CHRY),  benzo[b+k]fluoranthene, benzo[a]pyrene (B[a]P), 44 
indeno[1,2,3-cd]pyrene (I[cd]P) and dibenz[a,h]anthracene (D[ah]A); 7 carbonyl-OxyPAHs: 45 
1,4-naphthoquinone (1,4-NQ),  9-fluorenone (9-FLO), 2-methyl anthraquinone (2-MAQ), 2-46 
ethylanthraquinone (2-EAQ), 9,10-anthraquinone (9,10-ANQ), 2,3-dimethylanthraquinone 47 
(2,3-DMAQ), 7H-benz[d,e]anthracene-7-one (7H-BANT); 5 N-heterocycles: quinoline (QUI), 48 
8-methylquinoline (8-MQL), indole (IND), acridine (ACR), carbazole (CBZ); 3 O-49 
heterocycles: dibenzofuran (DBF), 2-methylbenzofuran (2-MBF), xanthene (XAN); 1 S-50 
heterocycle: thianaphthene (THIA); 3 NPAHs: 1-nitronaphthalene (1N-NAP),  2-nitrofluorene 51 
(2N-FLU), 9-nitroanthracene (9N-ANT) and internal standards comprising of naphthalene-d8, 52 
phenanthrene-d10, chrysene-d12 and perylene-d12, as well as acenaphthene-d10 and 53 
flouranthene-d10 surrogate standards. Anhydrous sodium sulphate (99% purity), n-hexane, 54 
dichloromethane and acetone (99.8% purity) were also sourced from Sigma Aldrich, Australia. 55 
QuEChERS extraction tubes (50mL-Cat# 982-5650) and QuEChERS clean up, dispersive SPE 56 
tubes (15 mL-Cat# 5982-5156) were purchased from Agilent Technologies, Australia.   57 
 58 
SI-Text 2: GC-MS analysis 59 
The concentrations of PAHs, oxy-PAHs, NPAHs and HPAHs in extracts were measured by an 60 
Agilent 7890 B gas chromatograph (GC) coupled to a mass spectrometer (MS) with a HP-5MS 61 
(30 m x 0.25 mm x 0.25 µm) column. The GC oven parameters were according to (Idowu et 62 
al., 2019b; 2020).  Sample volumes of 1 µl were injected into the system in splitless mode. The 63 
mass spectrometer was operated in an electron impact ionisation mode, at 70 eV, for all the 64 
measured analytes, as well as under selected ion monitoring mode. 65 
 66 
SI-Text 3: Quality assurance and quality control 67 
Throughout the extraction and analysis processes, strict quality assurance and quality control 68 
procedures were followed. Amber coloured glass vials were used throughout to minimise PAH 69 
loss from photolysis. Cross-contamination was checked by analysing laboratory blanks after 70 
every batch of 10 samples during GC-MS analysis. Target polar and non-polar PAHs were 71 
either not detected or below detection limits in the solvent blanks. Triplicates samples were 72 
analysed and considering the variation in physicochemical properties of different polar PAHs, 73 
we conducted an exclusive recovery rate experiment under optimised extraction conditions. 74 
Oyster tissue samples were replicated five times for the experiment. Tissues (1g) were spiked 75 
with 20µl of 100µg/ml acenaphthene-d10/fluoranthene-d10 (parent PAHs) and individual 76 
polar PAHs, extracted according to the QuEChERS method, fractionated and analysed. 77 
Unspiked tissue samples were also extracted and analysed for polar PAHs and concentrations 78 
of both spiked and unspiked samples used to compute their recovery rates. The recovery results 79 
for parent and polar PAHs are presented in Table S5 (supplementary information).  80 
 81 
 82 
 Table S1  83 
                   Concentration changes (µg/g d.w.) of HPAHs during the 86-day depuration study  84 

















































































































































































































































































































































































































































      
 85 
2-MBF (2-methylbenzofuran), DBF (dibenzofuran), XAN (xanthene), THIA (thianaphthene), QUI (quinolone), IND (indole), 8-MQL (8-methylquinoline), 86 
ACR (acridine) and CBZ (carbazole); values are mean±SD.  87 
 88 
Table S2  89 

















































































































































































































































































































































      
 91 
 1,4-NQ (1,4-naphthoquinone), 9-FLO (9-fluorenone), 9,10-ANQ (9,10-anthraquinone), 2-EAQ (2-ethylanthraquinone),  2-MAQ (2-methyl anthraquinone) 2,3-92 
DMAQ (2,3-dimethylanthraquinone) and 7H-BANT (7H-benz[d,e]anthracene-7-one); values are mean±SD. 93 
Table S3  94 




























































































































































Table S4 102 
Concentration changes (µg/g d.w.) of parent PAHs during the 86-day depuration study 103 





















































































































































































































      
























































































































































































































































































































































































































































      
 104 
ACENY (acenaphthylene), ACEN (acenaphthene), FLU (fluorine), PHEN (phenanthrene), ANTH (anthracene), FLUA (fluoranthene), PYR (pyrene)  B[a]A 105 
(benz[a] anthracene), CHRY (chrysene), B[b+k]F (benzo[b+k]fluoranthene), B[a]P (benzo[a] pyrene), I[cd])P (indeno[1,2,3-cd]pyrene) and D[a,h]A 106 
(dibenz[a,h]anthracene); values are mean±SD.107 
Table S5 108 




ACE-D10 (Acenaphthene-d10), FLU-D10 (Fluoranthene-d10), 1,4-NQ (1,4-naphthoquinone), 9-FLO (9-fluorenone), 9,10-ANQ (9,10-anthraquinone), 2-113 
MAQ (2-methyl anthraquinone), 2-EAQ (2-ethylanthraquinone),  2,3-DMAQ (2,3-dimethylanthraquinone), 7H-BANT (7H-benz[d,e]anthracene-7-one), 1N-114 
NAP (1-nitronaphthalene), 2N-ANT (2-nitroanthracene), 9N-FLU (9-nitrofluorene), 2-MBF (2-methylbenzofuran), XAN  (xanthene), THIA (thianaphthene), 115 
QUI (quinolone), IND (indole), 8-MQL (8-methylquinoline), ACRI (acridene) and CBZ (carbazole). 116 
Parent PAHs ACE-D10 FLU-D10       
 69.2 82.5       
Oxy-PAHs 1,4-NQ 9-FLO 9,10-ANQ 2-MAQ 2-EAQ 2,3-DMAQ 7H-BANT  
 44.6 92.8 90.9 79.1 82.1 81.7 81.8  
NPAHs 1N-NAP 2N-FLU 9N-ANT      
 66.6 79.8 92.1      
HPAHs 2-MBF XAN THIA QUI IND 8-MQL ACR CBZ 
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Fig. S1. Elimination kinetics of parent PAHs (bio-concentrated) (A – H), NPAHs (I – J) and 141 
oxyPAH (9-FLO) (K) for location A/B-sourced and control oysters. ACENY (acenaphthylene) 142 
PHEN (phenanthrene), ANTH (anthracene), FLUA (fluoranthene), PYR (pyrene), B[a]P (benzo[a] 143 
pyrene), I[cd])P (indeno[1,2,3-cd]pyrene), D[a,h]A (dibenz[a,h]anthracene), 2N-ANT (2-144 
nitroanthracene), 9N-FLU (9-nitrofluorene), 9-FLO (9-filuorenone). The lines represent the linear 145 
regression equations. 146 
 147 


























































































































































































































































































































































































Fig. S2. Polar and non-polar PAHs showing variable relationship of ln concentration (µg/g) lipid with 173 
time. 174 
ACEN (acenaphthene), FLU (fluorine), CHRY (chrysene), B[b+k]F (benzo[b+k]fluoranthene), 2-MBF 175 
(2-methylbenzofuran), DBF (dibenzofuran), 8-MQL (8-methylquinoline), IND (indole),  ACR (acridine), 176 
CBZ (carbazole), 1,4-NQ (1,4-naphthoquinone), 9,10-ANQ (9,10-anthraquinone), 2-MAQ (2-methyl 177 
anthraquinone),  2,3-DMAQ (2,3-dimethylanthraquinone), 2-EAQ (2-ethylanthraquinone) 7H-BANT 178 
(7H-benz[d,e]anthracene-7-one) and 1N-NAP (1-nitronaphthalene). 179 
  180 






























Fig. S3. Summary of k2 versus Log Kow following regression analysis for (A.) parent PAHs alone (B.) polar 186 
PAHs alone. Parent and polar PAHs subjected to regression analyses had k2 values significantly different 187 
(p < 0.05) from zero. LA is location A-sourced; LB is location B-sourced; C is control. 188 
 189 
 1 
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 14 
  15 
16 
Fig. 2. Mean concentrations (µg/g lipid) in logarithmic scale of (A) heterocyclic (B) 17 
oxygenated (C) nitrated and (D) parent PAHs in oysters sampled from an isolated 18 
waterway during the 86-day depuration study. Oysters were initially collected from 19 
locations A and B of a southeast Australian estuary and transferred to the isolated 20 
waterway in NSW.  The sampled oysters from locations A and B, and oysters from 21 
Camden Haven River (control) were used for an 86-day depuration study in the isolated 22 
waterway. Mean PAC concentrations were not significantly different (p > 0.05) (except 23 
for 1N-NAP), for the differently sourced oysters.  HPAHs are: 2-MBF (2-24 
methylbenzofuran), DBF (dibenzofuran), XAN (xanthene), THIA (thianaphthene), 25 
QUI (quinolone), IND (indole), 8-MQL (8-methylquinoline), ACR (acridine) and CBZ 26 
(carbazole). OxyPAHs are: 1,4-NQ (1,4-naphthoquinone), 9-FLO (9-fluorenone), 9,10-27 
ANQ (9,10-anthraquinone), 2-EAQ (2-ethylanthraquinone), 2-MAQ (2-methyl 28 
anthraquinone), 2,3-DMAQ (2,3-dimethylanthraquinone) and 7H-BANT (7H-29 
benz[d,e]anthracene-7-one). NPAHS are: 1N-NAP (1-nitronaphthalene), 2N-FLU (2-30 
nitroanthracene) and 9N-ANT (9-nitrofluorene). Parent PAHs are: ACENY 31 
(acenaphthylene), ACEN (acenaphthene), FLU (fluorine), PHEN (phenanthrene), 32 
ANTH (anthracene), FLUA (fluoranthene), PYR (pyrene),  B[a]A (benz[a] 33 
anthracene), CHRY (chrysene), B[b+k]F (benzo[b+k]fluoranthene), B[a]P (benzo[a] 34 
pyrene), D[a,h]A (dibenz[a,h]anthracene) and I[cd])P (indeno[1,2,3-cd]pyrene). 35 
Table 1  
Monitored PACs and their abbreviations 
Parent PAHs abbr. OxyPAHs abbr. HPAHs abbr. 
acenaphthylene ACENY 1,4-naphthoquinone 1,4-NQ quinoline QUI 
acenaphthene ACEN 9-fluorenone 9-FLO 8-methylquinoline 8-MQL 
fluorene FLU 2-methyl anthraquinone 2-MAQ indole IND 
phenanthrene PHEN 2-ethylanthraquinone 2-EAQ acridine ACR 
anthracene ANTH 9,10-anthraquinone 9,10-ANQ carbazole CBZ 
fluoranthene FLUA 2,3-dimethylanthraquinone 2,3-DMAQ dibenzofuran DBF 
pyrene PYR 7H-benz[d,e]anthracene-7-one 7H-BANT 2-methylbenzofuran 2-MBF 
benz[a]anthracene B[a]A NPAHs  xanthene XAN 
chrysene CHRY 1-nitronaphthalene 1N-NAP thianaphthene THIA 
benzo[b+k]fluoranthene B[b+k]F 2-nitrofluorene 2N-FLU INTERNAL STANDARDS  
benzo[a]pyrene B[a]P 9-nitroanthracene 9N-ANT naphthalene-d8  
indeno[1,2,3-cd]pyrene I[cd]P RECOVERY STANDARDS  phenanthrene-d10  
dibenz[a,h]anthracene D[ah]A Acenaphthene-d10 ACE-d10 chrysene-d12  
  flouranthene-d10 FLU-d10 perylene-d12  
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a  PACs:  ACENY (acenaphthylene), ACEN (acenaphthene), FLU (fluorene), PHEN (phenanthrene), ANTH (anthracene), FLUA  
(fluoranthene), PYR (pyrene),  B[a]A (benz[a] anthracene), CHRY (chrysene), B[b+k]F (benzo[b+k]fluoranthene), B[a]P (benzo[a] pyrene),                                  
I[cd])P (indeno[1,2,3-  cd]pyrene), D[a,h]A (dibenz[a,h]anthracene), 2N-FLU (2-nitrofluorene), 9N-ANT (9-nitroanthracene).  
k2 (elimination rate constant), t1/2  (half-life), t95 (time required to reach 95% steady-state).  
b  Log Kow values from Idowu et al., (2019) except I[cd])P and  D[a,h]A which were reported in  Gewurtz et al.,  2002.
  PACs a  Log Kow b Elimination 
rate constant 
k2 (day-1) 
    Half-life  
(t1/2) 
    t95     
  
Location A Location B Control Location A Location B Control Location A Location B Control 
ACENY 3.94 0.034 0.020 0.044 20.2 34.0 15.739 87.365 146.778 68.023 
PHEN 4.46 0.109 0.086 0.067 6.4 8.1 10.4 27.6 35.0 44.7 
ANTH 4.45 0.102 0.080 0.043 6.8 8.7 16.1 29.5 37.7 69.4 
FLUA 5.16 0.108 0.074 0.071 6.4 9.4 9.8 27.6 40.5 42.5 
PYR 4.88 0.103 0.078 0.072 6.7 8.9 9.7 29.0 38.5 41.8 
B[a]A 5.76 0.095 0.051 0.051 7.3 13.5 13.5 31.4 58.2 58.5 
CHRY 5.81 0.023 0.008 0.017 30.1 92.1 40.1 130.1 397.8 173.2 
B[b+k]F 5.78 0.035 0.004 0.007 19.7 171.6 98.5 85.0 741.5 425.5 
B[a]P 6.13 0.041 0.001 0.019 16.9 647.8 37.4 73.2 2799.8 161.8 
I[cd])P 6.75 0.039 0.029 0.031 17.9 23.6 22.1 77.1 102.2 95.7 
D[a,h]A 7 0.046 0.012 0.013 15.1 55.6 52.9 65.1 240.2 228.5 
2N-FLU 3.37 0.027 0.033 0.019 25.5 20.8 36.3 110.1 89.8 156.7 
9N-ANT 4.78 0.024 0.030 0.009 28.3 23.1 74.7 122.4 99.9 322.8 
9-FLO 3.58 0.013 0.013 0.009 53.9 51.5 74.0 232.8 222.6 319.7 
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a PACs: ACENY (acenaphthylene), ACEN (acenaphthene), FLU (fluorine), PHEN (phenanthrene), ANTH (anthracene), FLUA 
(fluoranthene), PYR (pyrene),  B[a]A (benz[a] anthracene), CHRY (chrysene), B[b+k]F (benzo[b+k]fluoranthene), B[a]P (benzo[a] 
pyrene), I[cd])P (indeno[1,2,3-cd]pyrene), D[a,h]A (dibenz[a,h]anthracene); 2N-FLU (2-nitrofluorene) and 9N-ANT (9-nitroanthracene). 
k2 (elimination rate constant), t1/2  (half-life), t95 (time required to reach 95% steady-state). Location A-sourced values used for 
comparison. B[b]F and B[k]F values were reported separately in the previous studies. b Comparative values not found in the literature.
  PACs a This study     Gewurtz et al., 2002   Thorsen et al., 2004   
  k2 (day-1) t1/2 t95  k2 (day-1) t1/2 t95 k2 (day-1) t1/2 t95 
ACENY 0.034 20.2 87.4 0.046 15.1 64.7 0.185 3.8 
ACEN 0.031 22.1 95.5 0.095 7.3 31.6 0.237 2.9 16.2 
PHEN 0.109 6.4 27.6 0.177 3.9 16.9 0.171 4.1 12.6 
ANTH 0.102 6.8 29.5 0.163 4.3 18.4 0.179 3.9 17.6 
FLUA 0.108 6.4 27.6 0.130 5.3 23.0 0.126 5.5 16.7 
PYR 0.103 6.7 29.0 0.144 4.8 20.8 0.164 4.2 23.9 
B[a]A 0.095 7.3 31.4 0.148 4.7 20.2 0.092 7.5 18.3 
CHRY 0.023 30.1 130.1 0.105 6.6 28.6 0.084 8.3 32.5 
B[b+k]F 0.035 19.7 85.0 0.103/0.037 6.7/18.7 29.1/81.8 0.083/0.059 8.4/11.8 35.9 
B[a]P 0.041 16.9 73.2  -  -  - 0.076  - 36.3/50.9 
I[cd])P 0.039 17.8 77.1 0.162 4.3 18.5 0.047 14.7  - 
D[a,h]A 0.046 15.1 65.1 0.048 14.4 63.0 0.069 15.1 63.7 
2N-FLUb 0.027 25.5 110.1  -  -  -  -  - 43.7 
9N-
ANTb 
0.024 28.3 122.4  -  -  -  -  -  - 
9-FLOb 0.013 53.9 232.8  -  -  -  -  -  - 
 
